Hi Lew,Loobie wrote: I just set up processes for manufacturing steel components; I can't imagine the depth and complexity of what setting up a lab type process overseen by the FDA would be like. Not cheap I would imagine.
Hi Chris,chrishasms wrote:I know if you look at the other MS therapies and the past stock performances they do well and they only offer a 30% chance of it even working.
Lyon wrote: Hi Lew, The President of Opexa has already stated that Tovaxin would cost about the same as the crabs but due to the time confines when shipping the blood and the vaccine they won't be able to make one huge factory to supply it for the world, as you could with a drug. Tovaxin is going to require multiple regional labs, all with the same quality control standards.
It seems that would take a while to set up and it seems that would be expensive.Bob
Users browsing this forum: No registered users